Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
18.223.237.218

Design of Condition-based Maintenance Framework for Process Operations Management in Pharmaceutical Continuous Manufacturing

By Ganesh, Sudarshan; Su, Qinglin; Vo, Le Bao Dan; Pepka, Nolan; Rentz, Benjamin; Vann, Lucas; Yazdanpanah, Nima; O'Connor, Thomas; Nagy, Zoltan K.; Reklaitis, Gintaras V.

Published on

Abstract

Continuous manufacturing, an emerging technology in the pharmaceutical industry, has the potential to increase the efficiency, and agility of pharmaceutical manufacturing processes. To realize these potential benefits of continuous operations, effectively managing materials, equipment, analyzers, and data is vital. Developments for continuous pharmaceutical manufacturing have led to novel technologies and methods for processing material, designing and configuring individual equipment and process analyzers, as well as implementing strategies for active process control. However, limited work has been reported on managing abnormal conditions during operations to prevent unplanned deviations and downtime and sustain system capabilities. Moreover, although the sourcing, analysis, and management of real-time data have received growing attention, limited discussion exists on the continued verification of the infrastructure for ensuring reliable operations. Hence, this work introduces condition-based maintenance (CBM) as a general strategy for continually verifying and sustaining advanced pharmaceutical manufacturing systems, with a focus on the continuous manufacture of oral solid drug products (OSD-CM). Frameworks, such as CBM, benefit unified efforts towards continued verification and operational excellence by leveraging process knowledge and the availability of real-time data. A vital implementation consideration for manufacturing operations management applications, such as CBM, is a systems architecture and an enabling infrastructure. This work outlines the systems architecture design for CBM in OSD-CM and highlights sample fault scenarios involving equipment and process analyzers. For illustrative purposes, this work also describes the infrastructure implemented on an OSD-CM testbed, which uses commercially available automation systems and leverages enterprise architecture standards. With the increasing digitalization of manufacturing operations in the pharmaceutical industry, proactively using process data towards modernizing maintenance practices is relevant to a single unit operation as well as to a series of physically integrated unit operations.

Journal

International Journal of Pharmaceutics. Volume 587, 2020, 119621

DOI

10.1016/j.ijpharm.2020.119621

Type of publication

Peer-reviewed journal

Affiliations

  • Purdue University
  • Applied Materials, Inc
  • FDA (U.S. Food and Drug Administration)

Article Classification

Research article

Classification Areas

  • PAT
  • Oral solid dose

Tags